HEALTH PROFESSIONAL · SOURCE READING
Treatment Options for Stage IVb Squamous Cell Carcinoma (SCC) and Adenocarcinoma of the Vagina
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Stage IVb Vaginal Cancer
Treatment options for stage IVb SCC and adenocarcinoma of the vagina include:
Source links and citations
Radiation therapy (for palliation of symptoms) with or without chemotherapy.
For patients with stage IVb disease, current therapy is inadequate. No established anticancer drugs have demonstrated clinical benefit, although patients are often treated with regimens used to treat cervical cancer.
Concurrent chemotherapy using fluorouracil or cisplatin-based therapy and radiation therapy is sometimes advocated on the basis of results extrapolated from cervical cancer management strategies.[1-3] Evidence is limited to small case series, and the incremental impact on patient survival and local disease control is not well defined.[Level of evidence C3] For more information, see Cervical Cancer Treatment.
Source links and citations
Because stage IVb vaginal cancer is rare, these patients are candidates for clinical trials to improve survival or local control. Information about ongoing clinical trials is available from the NCI website.
Source links and citations
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice
Triangle